A team of biologists at Queen Mary University of London has discovered that a neurohormone controlling appetite in humans has ...

Famed for her approach, Dr Jo Mennie, practitioner at Get Harley and co-founder of Løuco, is the go-to skin expert for ...

One of the most buzz-worthy skincare ingredients at the moment is all about plumping and replenishing the skin: peptides.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

A group of researchers from Arizona State University and University of Arizona have published their work on a new treatment ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...